These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 7528296

  • 1. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582.
    Pagani ED, Dundore RL, Bode DC, Bacon ER, Singh B, Lesher GY, Buchholz RA, Silver PJ.
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):403-10. PubMed ID: 7528296
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
    Silver PJ, Dundore RL, Bode DC, de Garavilla L, Buchholz RA, van Aller G, Hamel LT, Bacon E, Singh B, Lesher GY.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs.
    Vandeplassche GM, Hermans CF, de Chaffoy de Courcelles DR, D'Aubioul JA, Wouters LJ, De Clerck FF.
    J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769
    [Abstract] [Full Text] [Related]

  • 6. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 7. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
    Alvarez R, Banerjee GL, Bruno JJ, Jones GL, Littschwager K, Strosberg AM, Venuti MC.
    Mol Pharmacol; 1986 Jun; 29(6):554-60. PubMed ID: 3012320
    [Abstract] [Full Text] [Related]

  • 8. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
    Brunkhorst D, von der Leyen H, Meyer W, Schmidt-Schumacher C, Scholz H.
    Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds.
    de Cheffoy de Courcelles D, de Loore K, Freyne E, Janssen PA.
    J Pharmacol Exp Ther; 1992 Oct; 263(1):6-14. PubMed ID: 1328613
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the phosphodiesterase inhibition by 2-(3-methoxy-5-methylsulfinyl-2-thienyl)-1H-imidazo-(4,5-c)-pyridine HCl and its sulfide- and sulfone derivatives in myocardial preparations from failing human hearts.
    Bethke T, Klimkiewicz A, Meyer W, Schumacher C, Schmitz W, Scholz H, Starbatty J, Wenzlaff H, Zimmermann W.
    Arzneimittelforschung; 1995 Jul; 45(7):771-6. PubMed ID: 8573220
    [Abstract] [Full Text] [Related]

  • 11. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle.
    Silver PJ, Harris AL, Canniff PC, Lepore RE, Bentley RG, Hamel LT, Evans DB.
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):530-40. PubMed ID: 2470989
    [Abstract] [Full Text] [Related]

  • 12. Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion.
    Chiu T, Reid IA.
    J Pharmacol Exp Ther; 1996 Aug; 278(2):793-9. PubMed ID: 8768733
    [Abstract] [Full Text] [Related]

  • 13. [How to use PDE III inhibitors].
    Goto Y.
    Nihon Rinsho; 2007 May 28; 65 Suppl 5():49-56. PubMed ID: 17571365
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of phosphodiesterase III with milrinone increases renin secretion in human subjects.
    Chiu YJ, Hu SH, Reid IA.
    J Pharmacol Exp Ther; 1999 Jul 28; 290(1):16-9. PubMed ID: 10381754
    [Abstract] [Full Text] [Related]

  • 15. Multiple molecular forms of phosphodiesterase and the regulation of cardiac muscle contractility.
    Weishaar RE, Kobylarz-Singer DC, Quade MM, Steffen RP, Kaplan HR.
    J Cyclic Nucleotide Protein Phosphor Res; 1999 Jul 28; 11(7):513-27. PubMed ID: 2831259
    [Abstract] [Full Text] [Related]

  • 16. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
    Price B, Pyne NJ, Houslay MD.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4047-54. PubMed ID: 2825712
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
    Bivalacqua TJ, Champion HC, Rajasekaran M, Sikka SC, Kadowitz PJ, Doherty PC, Hellstrom WJ.
    J Urol; 1999 Nov 01; 162(5):1848-55. PubMed ID: 10524946
    [Abstract] [Full Text] [Related]

  • 18. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation.
    Lugnier C, Komas N.
    Eur Heart J; 1993 Nov 01; 14 Suppl I():141-8. PubMed ID: 8293765
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of cardiac phosphodiesterase III by the novel cardiotonic agent 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride.
    Sellin LC, Alajoutsijärvi A, Törnquist K, Fraser M, Pippuri A, Ojala I.
    Arzneimittelforschung; 1988 Dec 01; 38(12):1787-9. PubMed ID: 2854467
    [Abstract] [Full Text] [Related]

  • 20. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN, Shiloh AO, Sauermelch CF, Sulpizio A, Michell MP, Cieslinski LB, Torphy TJ, Ohlstein EH.
    J Cereb Blood Flow Metab; 1997 Feb 01; 17(2):210-9. PubMed ID: 9040501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.